低分子肝素在慢性阻塞性肺疾病急性加重期的疗效观察  

Therapeutic effect of low molecular heparin on treating acute exacerbation of chronic obstructive pulmonary disease

作　　者：朴瑛[1] 玄香兰[1] 

机构地区：[1]吉林省延边第二人民医院呼吸内科,吉林延吉133000

出　　处：《中国现代医生》2013年第30期118-119,122,共3页China Modern Doctor

摘　　要：目的观察低分子肝素在治疗慢性阻塞性肺疾病急性加重期的临床疗效。方法选择2011年9月-2012年9月收治的慢性阻塞性肺疾病急性加重期患者110例,分为观察组56例和对照组54例。两组患者均给予常规治疗,观察组加用低分子肝素,并连续应用1周。观察治疗前后血气分析、症状改善时间、住院天数。结果观察组血气分析、症状改善时间、住院天数明显优于对照组(P<0.05)。结论低分子肝素在治疗慢性阻塞性肺疾病急性加重期疗效确切,值得临床推广应用。Objective To explore the clinical effect of low molecular heparin in the treatment of acute exacerbations of chronic obstructive pulmonary disease （AECOPD）. Methods A total of 110 cases of AECOPD were accepted from Septem- ber 2011 to September 2012. patients were divided into study group and control group and all received routine treat- ment. study group were extragiven low molecular heparin for 1 week continuous, blood gas analysis and improving time and hospitalization time were detected before treatmSent and the 1 week after treatment. Results Every index of study group was superior to the control group, there was statistical difference between the two groups （P〈0.05）. Conclusion Therapeutic effect on treating AECOPD with low molecular heparin was sure, which is worth popularizing.

关 键 词：低分子肝素 慢性阻塞性肺疾病 急性加重期 

分 类 号：R563.9[医药卫生—呼吸系统] R969.4[医药卫生—内科学]